BioForm Medical, Inc. Receives FDA Approval for Mixing Lidocaine With RADIESSE(r) Dermal Filler

SAN MATEO, Calif., July 16, 2009 (GLOBE NEWSWIRE) -- BioForm Medical, Inc. (Nasdaq:BFRM) today announced U.S. Food and Drug Administration (FDA) approval for a method of mixing RADIESSE(r) dermal filler with lidocaine, which, in clinical trials, has demonstrated an improvement in patient comfort and an increase in patient satisfaction with RADIESSE dermal filler procedures. BioForm Medical will immediately begin commercial efforts to educate physicians to use this method of mixing RADIESSE dermal filler with lidocaine.